Therapeutics for autoimmune kidney disease: synthetic antigens

Kira Astakhova (Inventor)

Research output: Patent

154 Downloads (Pure)


The present invention concerns therapeutics for autoimmune diseases and provides removal of inflammation-causing autoantibodies. In order to target the disease in the most efficient manner, a nanoconjugate complex is provided, comprising at least one specific antigen component recognized by autoantibodies related to the autoimmune disease, at least one helper moiety, and a nanoparticle carrier connecting the components. Each component of the therapeutic nanoconjugate complex has a specific function, yielding a nanoconjugate complex which facilitates specific binding, forming a stable antibody- therapeutic complex in the blood stream and rapid clearance of this complex to the liver.

Original languageEnglish
IPCA61P 13/ 12 A I
Patent numberWO2019149946
Filing date02/02/2018
Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
Priority date02/02/2018
Priority numberEP20180154924
Publication statusPublished - 8 Aug 2019


Dive into the research topics of 'Therapeutics for autoimmune kidney disease: synthetic antigens'. Together they form a unique fingerprint.

Cite this